Journal article
Anand Kumar Sharma, Christian Wolfrum
EMBO Molecular Medicine, 2023, pp. e18209
EMBO Molecular Medicine, 2023, pp. e18209
Semantic Scholar
DOI
PubMedCentral
PubMed
Cite
Cite
APA
Click to copy
Sharma, A. K., & Wolfrum, C. (2023). DGAT inhibition at the post-absorptive phase reduces plasma FA by increasing FA oxidation. EMBO Molecular Medicine, e18209.
Chicago/Turabian
Click to copy
Sharma, Anand Kumar, and Christian Wolfrum. “DGAT Inhibition at the Post-Absorptive Phase Reduces Plasma FA by Increasing FA Oxidation.” EMBO Molecular Medicine (2023): e18209.
MLA
Click to copy
Sharma, Anand Kumar, and Christian Wolfrum. “DGAT Inhibition at the Post-Absorptive Phase Reduces Plasma FA by Increasing FA Oxidation.” EMBO Molecular Medicine, 2023, p. e18209.
BibTeX Click to copy
@article{sharma2023a,
title = {DGAT inhibition at the post-absorptive phase reduces plasma FA by increasing FA oxidation},
year = {2023},
journal = {EMBO Molecular Medicine},
pages = {e18209},
author = {Sharma, Anand Kumar and Wolfrum, Christian}
}
Abstract
In this Correspondence, A. Sharma & C. Wolfrum report that DGAT1/2 pharmacological inhibition at post‐absorptive phase in mice leads to increased fatty acid oxidation and reduced plasma fatty acid levels, which could open new therapeutic avenues to avoid GI complications observed in clinical trials.